INFLIXIMAB DOWNREGULATES INTERFERON-γ PRODUCTION IN ACTIVATED GUT T-LYMPHOCYTES FROM PATIENTS WITH CROHN'S DISEASE

This publication has 22 references indexed in Scilit:

• Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
  New England Journal of Medicine, 1999
• Staphylococcal enterotoxin‐A directly stimulates signal transduction and interferon‐γ production in psoriatic T‐cell lines
  Tissue Antigens, 1998
• Spontaneous secretion of interferon γ and interleukin 4 by human intraepithelial and lamina propria gut lymphocytes
  Gut, 1998
• Immunomodulation of Crohn's disease using TNF-αneutralizing monoclonal antibodies
  Clinical Nutrition, 1997
• Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell lines
  Cancer Genetics and Cytogenetics, 1995
• Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
  Gastroenterology, 1995
• Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions
  Cytokine, 1995
• The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation.
  The Journal of Experimental Medicine, 1993
• Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers.
  Gut, 1991
• Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells
  Clinical and Experimental Immunology, 1991